October 28, 2010 | REPLICor to disclose interim REP 9AC clinical efficacy data in patients with chronic hepatitis B at the 61st annual meeting of the AASLD in Boston, U.S.A. |
| |
March 18, 2010 | REPLICor to present interim REP 9AC clinical efficacy data at the 20th annual meeting of the APASL in Beijing, China |
| |
December 8, 2009 | Dr. Allison Jilbert presents preclinical efficacy data for REP 9AC in DHBV infected Pekin ducks |
| |
December 2, 2009 | REPLICor publishes data on the activity and safety of amphipathic DNA polymers (APs) in cytomegalovirus infection |
| |
April 23, 2009 | Publication of REPLICor’s first in class HCV entry inhibitor based on its amphipathic DNA polymer technology |
| |
April 16, 2009 | REPLICor publishes data on mechanism of action and pre-clinical efficacy of amphipathic DNA polymers (APs) in HCV infection |
| |
March 31, 2009 | REPLICor to present preclinical data showing a curative response to hepatitis B infection with its drug at the 1st Annual Girindus Leaders in Oligonucletides Meeting |
| |
March, 2009 | REPLICor initiates dosing of human patients with its drug |
| |
February, 2009 | REPLICor receives IRB approval to conduct a phase I / II trial to test the safety and efficacy of its drug in patients with chronic hepatitis B and hepatitis C |
| |
April 13, 2008 | REPLICor to Present at the 21st International Conference on Antiviral Research |
| |
January 10, 2008
| REPLICor : Une Entreprise Audacieuse (French only) |
| |
December 06, 2007 | REPLICor’s Data on REP 9C / REP 9AC Presented at the HEPDART Meeting |
| |
December 04, 2007 | REPLICor Recognized as a Top 10 Life Sciences Companies in Canada |
| |
November 30, 2007 | REPLICor Receives Notice of Allowance for Key Patent Application |
| |
September 16, 2007 | REPLICor to Present at the RSC Virus Molecular Interactions Conference |
| |
September 10, 2007 | REPLICor Collaborators to Present at the HBV Meeting |
| |
September 08, 2007 | REPLICor to Present at the 14th Symposium of Hepatitis C and Related Viruses |
| |
April 23, 2007 | REPLICor to Present at 20th International Conference on Antiviral Research |
| |
February 28, 2007 | REPLICor to Present at the 3rd Annual Viral Hepatitis in Drug Discovery & Development World Summit |
| |
October 24, 2006 | REPLICor to disclose results of its first-in-class drugs against hepatitis C |
| |
September 19, 2006 | REPLICor's Drug Activity in the Metabolic Syndrome |
| |
June 21, 2006 | REPLICor Presenting at Metabolic Diseases Summit |
| |
May 05, 2006 | REPLICor to present at the American Society for Microbiology General Meeting 2006 |
| |
May 05, 2006 | REPLICor to present at the 19th International Conference on Antiviral Research |
| |
May 05, 2006 | Oligos Enable New Classes of Therapeutics |
| |
April 28, 2006 | REPLICor to present at TIDES 2006 |
| |
April 22, 2006 | REPLICor, NIAID identify potential anti-prion therapeutic |
| |
April 5, 2006 | REPLICor’s Antiviral Drug Is Active against H5N1 Avian Flu |
| |
November 1st, 2005 | REPLICor’s Antiviral Drug Promises Potent Activity against H5N1 Avian Flu |
| |
April 11, 2005 | REPLICor Describes its Corporate Strategies in the Biomed Business Journal |
| |
March 30, 2005 | REPLICor to Disclose Unique Broad Spectrum Antiviral Drug |
| |
November 10, 2004 | Girindus to Produce Antiviral Treatment for Canada's Replicor |
| |
November 8, 2004 | REPLICor Named One of Canada’s Top Ten Life Science Companies |